GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanadaBis Capital Inc (TSXV:CANB) » Definitions » COGS-to-Revenue

CanadaBis Capital (TSXV:CANB) COGS-to-Revenue : 0.52 (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is CanadaBis Capital COGS-to-Revenue?

CanadaBis Capital's Cost of Goods Sold for the three months ended in Jan. 2024 was C$2.25 Mil. Its Revenue for the three months ended in Jan. 2024 was C$4.31 Mil.

CanadaBis Capital's COGS to Revenue for the three months ended in Jan. 2024 was 0.52.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. CanadaBis Capital's Gross Margin % for the three months ended in Jan. 2024 was 47.78%.


CanadaBis Capital COGS-to-Revenue Historical Data

The historical data trend for CanadaBis Capital's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanadaBis Capital COGS-to-Revenue Chart

CanadaBis Capital Annual Data
Trend Nov16 Dec17 Dec18 Jul19 Jul20 Jul21 Jul22 Jul23
COGS-to-Revenue
Get a 7-Day Free Trial - 0.74 0.63 0.52 0.47

CanadaBis Capital Quarterly Data
Mar19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.55 0.28 0.54 0.52

CanadaBis Capital COGS-to-Revenue Calculation

CanadaBis Capital's COGS to Revenue for the fiscal year that ended in Jul. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=10.438 / 22.222
=0.47

CanadaBis Capital's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=2.25 / 4.309
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CanadaBis Capital  (TSXV:CANB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

CanadaBis Capital's Gross Margin % for the three months ended in Jan. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 2.25 / 4.309
=47.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


CanadaBis Capital COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of CanadaBis Capital's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


CanadaBis Capital (TSXV:CANB) Business Description

Traded in Other Exchanges
Address
PO Box 850, Rocky Mountain House, AB, CAN, T4T 1A6
CanadaBis Capital Inc is a vertically-integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extraction and tolling. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premise owned and operated by the Company. Extraction and tolling segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extraction and tolling.
Executives
Garfield Richards Senior Officer

CanadaBis Capital (TSXV:CANB) Headlines

From GuruFocus